References
- 1. Borchers AT, Lee JL, Naguwa SM, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun Rev. 2008 Sep; 7(8):598-605.
- 2. Chave TA, Mortimer NJ, Sladden MJ, et al. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol. Aug 2005;153(2): 241-53.
- 3. Tomasini C, Derlino F, Quaglino P, et al. From erythema multiforme to toxic epidermal necrolysis. Same spectrum or different diseases? G Ital Dermatol Venereol. 2014 Apr;149(2):243-61.
- 4. Abela C, Hartmann CE, De Leo A, et al. Toxic epidermal necrolysis (TEN): The Chelsea and Westminster Hospital wound management algorithm. J Plast Reconstr Aesthet Surg. 2014 Aug; 67(8):1026-32.
- 5. Freiman A, Borsuk D, Sasseville D. Dermatologic emergencies. CMAJ November 22, 2005; 173 (11).
- 6. Khalifian S, Ibrahim Z, Lilo MT, et al. Toxic epidermal necrolysis. Eplasty. 2014.
- 7. Huang YC, Li YC, Chen TJ. The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol. 2012 Aug;167(2): 424-32.
- 8. Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010 Dec 16; 5:39.
- 9. Zajicek, R, Pintar, D, Broz, L, Suca, H, Königova, R. “Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008”. Journal of the European Academy of Dermatology and Venereology: JEADV 2012,26 (5): 639-43.
- 10. Schwartz, RA, McDonough, PH, Lee, BW. “Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.” Journal of the American Academy of Dermatology 2013,69 (2): 187, 203-4.
- 11. Schwartz, RA; McDonough, PH; Lee, BW. “Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.” Journal of the American Academy of Dermatology 2013,69 (2): 173, 185-6.
- 12. Yang Y, Xu J, Li F, et al. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Int J Dermatol. 2009 Oct;48(10):1122-8.